News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference

CUPERTINO, Calif., June 12 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present a corporate overview at the Needham & Company, LLC's Fifth Annual Biotechnology and Medical Technology Conference on Wednesday, June 14th at 8:30 a.m. EST. The conference is taking place at The New York Palace Hotel in New York City, New York.


A live audio webcast of the presentation will be available by accessing DURECT's homepage at and clicking "Investor Relations."

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. The company is developing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time to treat chronic and episodic diseases and conditions.

CONTACT: Schond L. Greenway, Vice President, Investor Relations and Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom:
AP Archive:
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
Web site: